1 Gastrointestinal Stromal Tumor (GIST) Drug Market Overview 1.1 Product Overview and Scope of Gastrointestinal Stromal Tumor (GIST) Drug 1.2 Gastrointestinal Stromal Tumor (GIST) Drug Segment by Type 1.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Amcasertib 1.2.3 Anagrelide hydrochloride CR 1.2.4 APG-1351 1.2.5 Binimetinib 1.2.6 Others 1.3 Gastrointestinal Stromal Tumor (GIST) Drug Segment by Application 1.3.1 Gastrointestinal Stromal Tumor (GIST) Drug Sales Comparison by Application: (2021-2027) 1.3.2 Clinic 1.3.3 Hospital 1.3.4 Others 1.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Estimates and Forecasts 1.4.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue 2016-2027 1.4.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales 2016-2027 1.4.3 Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Region: 2016 Versus 2021 Versus 2027 2 Gastrointestinal Stromal Tumor (GIST) Drug Market Competition by Manufacturers 2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Manufacturers (2016-2021) 2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Sites, Area Served, Product Type 2.5 Gastrointestinal Stromal Tumor (GIST) Drug Market Competitive Situation and Trends 2.5.1 Gastrointestinal Stromal Tumor (GIST) Drug Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Gastrointestinal Stromal Tumor (GIST) Drug Players Market Share by Revenue 2.5.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Gastrointestinal Stromal Tumor (GIST) Drug Retrospective Market Scenario by Region 3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Retrospective Market Scenario in Revenue by Region: 2016-2021 3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Retrospective Market Scenario in Sales by Region: 2016-2021 3.3 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Facts & Figures by Country 3.3.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country 3.3.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Facts & Figures by Country 3.4.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country 3.4.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Facts & Figures by Region 3.5.1 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region 3.5.2 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Market Facts & Figures by Country 3.6.1 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country 3.6.2 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Facts & Figures by Country 3.7.1 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country 3.7.2 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Gastrointestinal Stromal Tumor (GIST) Drug Historic Market Analysis by Type 4.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2016-2021) 4.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Type (2016-2021) 4.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Type (2016-2021) 5 Global Gastrointestinal Stromal Tumor (GIST) Drug Historic Market Analysis by Application 5.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2016-2021) 5.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Application (2016-2021) 5.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Ariad Pharmaceuticals, Inc. 6.1.1 Ariad Pharmaceuticals, Inc. Corporation Information 6.1.2 Ariad Pharmaceuticals, Inc. Description and Business Overview 6.1.3 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Ariad Pharmaceuticals, Inc. Product Portfolio 6.1.5 Ariad Pharmaceuticals, Inc. Recent Developments/Updates 6.2 Arog Pharmaceuticals, Inc. 6.2.1 Arog Pharmaceuticals, Inc. Corporation Information 6.2.2 Arog Pharmaceuticals, Inc. Description and Business Overview 6.2.3 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Arog Pharmaceuticals, Inc. Product Portfolio 6.2.5 Arog Pharmaceuticals, Inc. Recent Developments/Updates 6.3 Array BioPharma Inc. 6.3.1 Array BioPharma Inc. Corporation Information 6.3.2 Array BioPharma Inc. Description and Business Overview 6.3.3 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Array BioPharma Inc. Product Portfolio 6.3.5 Array BioPharma Inc. Recent Developments/Updates 6.4 Astex Pharmaceuticals, Inc. 6.4.1 Astex Pharmaceuticals, Inc. Corporation Information 6.4.2 Astex Pharmaceuticals, Inc. Description and Business Overview 6.4.3 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Astex Pharmaceuticals, Inc. Product Portfolio 6.4.5 Astex Pharmaceuticals, Inc. Recent Developments/Updates 6.5 Blueprint Medicines Corporation 6.5.1 Blueprint Medicines Corporation Corporation Information 6.5.2 Blueprint Medicines Corporation Description and Business Overview 6.5.3 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Blueprint Medicines Corporation Product Portfolio 6.5.5 Blueprint Medicines Corporation Recent Developments/Updates 6.6 Boston Biomedical, Inc. 6.6.1 Boston Biomedical, Inc. Corporation Information 6.6.2 Boston Biomedical, Inc. Description and Business Overview 6.6.3 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Boston Biomedical, Inc. Product Portfolio 6.6.5 Boston Biomedical, Inc. Recent Developments/Updates 6.7 Calithera Biosciences, Inc. 6.6.1 Calithera Biosciences, Inc. Corporation Information 6.6.2 Calithera Biosciences, Inc. Description and Business Overview 6.6.3 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Calithera Biosciences, Inc. Product Portfolio 6.7.5 Calithera Biosciences, Inc. Recent Developments/Updates 6.8 Chipscreen Biosciences Ltd 6.8.1 Chipscreen Biosciences Ltd Corporation Information 6.8.2 Chipscreen Biosciences Ltd Description and Business Overview 6.8.3 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2016-2021) 6.8.4 Chipscreen Biosciences Ltd Product Portfolio 6.8.5 Chipscreen Biosciences Ltd Recent Developments/Updates 6.9 Deciphera Pharmaceuticals, LLC 6.9.1 Deciphera Pharmaceuticals, LLC Corporation Information 6.9.2 Deciphera Pharmaceuticals, LLC Description and Business Overview 6.9.3 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2016-2021) 6.9.4 Deciphera Pharmaceuticals, LLC Product Portfolio 6.9.5 Deciphera Pharmaceuticals, LLC Recent Developments/Updates 6.10 F. Hoffmann-La Roche Ltd. 6.10.1 F. Hoffmann-La Roche Ltd. Corporation Information 6.10.2 F. Hoffmann-La Roche Ltd. Description and Business Overview 6.10.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2016-2021) 6.10.4 F. Hoffmann-La Roche Ltd. Product Portfolio 6.10.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates 6.11 Horizon Pharma Plc 6.11.1 Horizon Pharma Plc Corporation Information 6.11.2 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Description and Business Overview 6.11.3 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2016-2021) 6.11.4 Horizon Pharma Plc Product Portfolio 6.11.5 Horizon Pharma Plc Recent Developments/Updates 6.12 Immunicum AB 6.12.1 Immunicum AB Corporation Information 6.12.2 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Description and Business Overview 6.12.3 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2016-2021) 6.12.4 Immunicum AB Product Portfolio 6.12.5 Immunicum AB Recent Developments/Updates 6.13 Jiangsu Hengrui Medicine Co., Ltd. 6.13.1 Jiangsu Hengrui Medicine Co., Ltd. Corporation Information 6.13.2 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Description and Business Overview 6.13.3 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2016-2021) 6.13.4 Jiangsu Hengrui Medicine Co., Ltd. Product Portfolio 6.13.5 Jiangsu Hengrui Medicine Co., Ltd. Recent Developments/Updates 6.14 Kolltan Pharmaceuticals, Inc. 6.14.1 Kolltan Pharmaceuticals, Inc. Corporation Information 6.14.2 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Description and Business Overview 6.14.3 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2016-2021) 6.14.4 Kolltan Pharmaceuticals, Inc. Product Portfolio 6.14.5 Kolltan Pharmaceuticals, Inc. Recent Developments/Updates 6.15 Natco Pharma Limited 6.15.1 Natco Pharma Limited Corporation Information 6.15.2 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Description and Business Overview 6.15.3 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2016-2021) 6.15.4 Natco Pharma Limited Product Portfolio 6.15.5 Natco Pharma Limited Recent Developments/Updates 6.16 Nerviano Medical Sciences S.r.l. 6.16.1 Nerviano Medical Sciences S.r.l. Corporation Information 6.16.2 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Description and Business Overview 6.16.3 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2016-2021) 6.16.4 Nerviano Medical Sciences S.r.l. Product Portfolio 6.16.5 Nerviano Medical Sciences S.r.l. Recent Developments/Updates 6.17 Novartis AG 6.17.1 Novartis AG Corporation Information 6.17.2 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Description and Business Overview 6.17.3 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2016-2021) 6.17.4 Novartis AG Product Portfolio 6.17.5 Novartis AG Recent Developments/Updates 6.18 Omeros Corporation 6.18.1 Omeros Corporation Corporation Information 6.18.2 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Description and Business Overview 6.18.3 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2016-2021) 6.18.4 Omeros Corporation Product Portfolio 6.18.5 Omeros Corporation Recent Developments/Updates 7 Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Cost Analysis 7.1 Gastrointestinal Stromal Tumor (GIST) Drug Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Gastrointestinal Stromal Tumor (GIST) Drug 7.4 Gastrointestinal Stromal Tumor (GIST) Drug Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Gastrointestinal Stromal Tumor (GIST) Drug Distributors List 8.3 Gastrointestinal Stromal Tumor (GIST) Drug Customers 9 Gastrointestinal Stromal Tumor (GIST) Drug Market Dynamics 9.1 Gastrointestinal Stromal Tumor (GIST) Drug Industry Trends 9.2 Gastrointestinal Stromal Tumor (GIST) Drug Growth Drivers 9.3 Gastrointestinal Stromal Tumor (GIST) Drug Market Challenges 9.4 Gastrointestinal Stromal Tumor (GIST) Drug Market Restraints 10 Global Market Forecast 10.1 Gastrointestinal Stromal Tumor (GIST) Drug Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Gastrointestinal Stromal Tumor (GIST) Drug by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Gastrointestinal Stromal Tumor (GIST) Drug by Type (2022-2027) 10.2 Gastrointestinal Stromal Tumor (GIST) Drug Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Gastrointestinal Stromal Tumor (GIST) Drug by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Gastrointestinal Stromal Tumor (GIST) Drug by Application (2022-2027) 10.3 Gastrointestinal Stromal Tumor (GIST) Drug Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Gastrointestinal Stromal Tumor (GIST) Drug by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Gastrointestinal Stromal Tumor (GIST) Drug by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) Growth Rate Comparison by Type (2021-2027) Table 2. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) Comparison by Application (2021-2027) Table 3. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Covered in This Study Table 5. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) of Key Manufacturers (2016-2021) Table 6. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Manufacturers (2016-2021) Table 7. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Gastrointestinal Stromal Tumor (GIST) Drug Average Price (USD/Pcs) of Key Manufacturers (2016-2021) Table 10. Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Sites and Area Served Table 11. Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Product Type Table 12. Global Gastrointestinal Stromal Tumor (GIST) Drug Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Gastrointestinal Stromal Tumor (GIST) Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastrointestinal Stromal Tumor (GIST) Drug as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2016-2021) & (K Pcs) Table 16. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Region (2016-2021) Table 17. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2016-2021) & (K Pcs) Table 19. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Country (2016-2021) Table 20. North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Country (2016-2021) Table 22. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2016-2021) & (K Pcs) Table 23. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Country (2016-2021) Table 24. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2016-2021) & (K Pcs) Table 27. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Region (2016-2021) Table 30. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2016-2021) & (K Pcs) Table 31. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Country (2016-2021) Table 32. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2016-2021) & (K Pcs) Table 35. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Country (2016-2021) Table 38. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) by Type (2016-2021) Table 39. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2016-2021) Table 40. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million US$) by Type (2016-2021) Table 41. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Type (2016-2021) Table 42. Global Gastrointestinal Stromal Tumor (GIST) Drug Price (USD/Pcs) by Type (2016-2021) Table 43. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) by Application (2016-2021) Table 44. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2016-2021) Table 45. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million US$) by Application (2016-2021) Table 46. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Application (2016-2021) Table 47. Global Gastrointestinal Stromal Tumor (GIST) Drug Price (USD/Pcs) by Application (2016-2021) Table 48. Ariad Pharmaceuticals, Inc. Corporation Information Table 49. Ariad Pharmaceuticals, Inc. Description and Business Overview Table 50. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 51. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Table 52. Ariad Pharmaceuticals, Inc. Recent Developments/Updates Table 53. Arog Pharmaceuticals, Inc. Corporation Information Table 54. Arog Pharmaceuticals, Inc. Description and Business Overview Table 55. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 56. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Table 57. Arog Pharmaceuticals, Inc. Recent Developments/Updates Table 58. Array BioPharma Inc. Corporation Information Table 59. Array BioPharma Inc. Description and Business Overview Table 60. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 61. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Table 62. Array BioPharma Inc. Recent Developments/Updates Table 63. Astex Pharmaceuticals, Inc. Corporation Information Table 64. Astex Pharmaceuticals, Inc. Description and Business Overview Table 65. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 66. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Table 67. Astex Pharmaceuticals, Inc. Recent Developments/Updates Table 68. Blueprint Medicines Corporation Corporation Information Table 69. Blueprint Medicines Corporation Description and Business Overview Table 70. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 71. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Table 72. Blueprint Medicines Corporation Recent Developments/Updates Table 73. Boston Biomedical, Inc. Corporation Information Table 74. Boston Biomedical, Inc. Description and Business Overview Table 75. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 76. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Table 77. Boston Biomedical, Inc. Recent Developments/Updates Table 78. Calithera Biosciences, Inc. Corporation Information Table 79. Calithera Biosciences, Inc. Description and Business Overview Table 80. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 81. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Table 82. Calithera Biosciences, Inc. Recent Developments/Updates Table 83. Chipscreen Biosciences Ltd Corporation Information Table 84. Chipscreen Biosciences Ltd Description and Business Overview Table 85. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 86. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product Table 87. Chipscreen Biosciences Ltd Recent Developments/Updates Table 88. Deciphera Pharmaceuticals, LLC Corporation Information Table 89. Deciphera Pharmaceuticals, LLC Description and Business Overview Table 90. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 91. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product Table 92. Deciphera Pharmaceuticals, LLC Recent Developments/Updates Table 93. F. Hoffmann-La Roche Ltd. Corporation Information Table 94. F. Hoffmann-La Roche Ltd. Description and Business Overview Table 95. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 96. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Table 97. F. Hoffmann-La Roche Ltd. Recent Developments/Updates Table 98. Horizon Pharma Plc Corporation Information Table 99. Horizon Pharma Plc Description and Business Overview Table 100. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 101. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product Table 102. Horizon Pharma Plc Recent Developments/Updates Table 103. Immunicum AB Corporation Information Table 104. Immunicum AB Description and Business Overview Table 105. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 106. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product Table 107. Immunicum AB Recent Developments/Updates Table 108. Jiangsu Hengrui Medicine Co., Ltd. Corporation Information Table 109. Jiangsu Hengrui Medicine Co., Ltd. Description and Business Overview Table 110. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 111. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Table 112. Jiangsu Hengrui Medicine Co., Ltd. Recent Developments/Updates Table 113. Kolltan Pharmaceuticals, Inc. Corporation Information Table 114. Kolltan Pharmaceuticals, Inc. Description and Business Overview Table 115. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 116. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Table 117. Kolltan Pharmaceuticals, Inc. Recent Developments/Updates Table 118. Natco Pharma Limited Corporation Information Table 119. Natco Pharma Limited Description and Business Overview Table 120. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 121. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product Table 122. Natco Pharma Limited Recent Developments/Updates Table 123. Nerviano Medical Sciences S.r.l. Corporation Information Table 124. Nerviano Medical Sciences S.r.l. Description and Business Overview Table 125. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 126. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Product Table 127. Nerviano Medical Sciences S.r.l. Recent Developments/Updates Table 128. Novartis AG Corporation Information Table 129. Novartis AG Description and Business Overview Table 130. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 131. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product Table 132. Novartis AG Recent Developments/Updates Table 133. Omeros Corporation Corporation Information Table 134. Omeros Corporation Description and Business Overview Table 135. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 136. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Table 137. Omeros Corporation Recent Developments/Updates Table 138. Production Base and Market Concentration Rate of Raw Material Table 139. Key Suppliers of Raw Materials Table 140. Gastrointestinal Stromal Tumor (GIST) Drug Distributors List Table 141. Gastrointestinal Stromal Tumor (GIST) Drug Customers List Table 142. Gastrointestinal Stromal Tumor (GIST) Drug Market Trends Table 143. Gastrointestinal Stromal Tumor (GIST) Drug Growth Drivers Table 144. Gastrointestinal Stromal Tumor (GIST) Drug Market Restraints Table 145. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Type (2022-2027) & (K Pcs) Table 146. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share Forecast by Type (2022-2027) Table 147. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Forecast by Type (2022-2027) & (US$ Million) Table 148. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share Forecast by Type (2022-2027) Table 149. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Application (2022-2027) & (K Pcs) Table 150. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share Forecast by Application (2022-2027) Table 151. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Forecast by Application (2022-2027) & (US$ Million) Table 152. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share Forecast by Application (2022-2027) Table 153. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Region (2022-2027) & (K Pcs) Table 154. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share Forecast by Region (2022-2027) Table 155. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Forecast by Region (2022-2027) & (US$ Million) Table 156. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share Forecast by Region (2022-2027) Table 157. Research Programs/Design for This Report Table 158. Key Data Information from Secondary Sources Table 159. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Gastrointestinal Stromal Tumor (GIST) Drug Figure 2. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Type in 2020 & 2027 Figure 3. Amcasertib Product Picture Figure 4. Anagrelide hydrochloride CR Product Picture Figure 5. APG-1351 Product Picture Figure 6. Binimetinib Product Picture Figure 7. Others Product Picture Figure 8. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application in 2020 & 2027 Figure 9. Clinic Figure 10. Hospital Figure 11. Others Figure 12. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size 2016-2027 (US$ Million) Figure 14. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales 2016-2027 (K Pcs) Figure 15. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 16. Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Manufacturers in 2020 Figure 17. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Manufacturers in 2020 Figure 18. The Global 5 and 10 Largest Gastrointestinal Stromal Tumor (GIST) Drug Players: Market Share by Revenue in 2020 Figure 19. Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 20. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Region (2016-2021) Figure 21. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Region in 2020 Figure 22. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Region (2016-2021) Figure 23. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Region in 2020 Figure 24. U.S. Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. Canada Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Germany Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. France Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. U.K. Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Italy Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. Russia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. China Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Japan Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. South Korea Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. India Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Australia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Taiwan Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Indonesia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Thailand Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Malaysia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Philippines Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Vietnam Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Mexico Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Brazil Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Argentina Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Turkey Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Saudi Arabia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. U.A.E Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 48. Sales Market Share of Gastrointestinal Stromal Tumor (GIST) Drug by Type (2016-2021) Figure 49. Sales Market Share of Gastrointestinal Stromal Tumor (GIST) Drug by Application (2016-2021) Figure 50. Sales Market Share of Gastrointestinal Stromal Tumor (GIST) Drug by Application in 2020 Figure 51. Revenue Share of Gastrointestinal Stromal Tumor (GIST) Drug by Application (2016-2021) Figure 52. Revenue Share of Gastrointestinal Stromal Tumor (GIST) Drug by Application in 2020 Figure 53. Manufacturing Cost Structure of Gastrointestinal Stromal Tumor (GIST) Drug Figure 54. Manufacturing Process Analysis of Gastrointestinal Stromal Tumor (GIST) Drug Figure 55. Gastrointestinal Stromal Tumor (GIST) Drug Industrial Chain Analysis Figure 56. Channels of Distribution Figure 57. Distributors Profiles Figure 58. Bottom-up and Top-down Approaches for This Report Figure 59. Data Triangulation Figure 60. Key Executives Interviewed

Ariad Pharmaceuticals, Inc. Arog Pharmaceuticals, Inc. Array BioPharma Inc. Astex Pharmaceuticals, Inc. Blueprint Medicines Corporation Boston Biomedical, Inc. Calithera Biosciences, Inc. Chipscreen Biosciences Ltd Deciphera Pharmaceuticals, LLC F. Hoffmann-La Roche Ltd. Horizon Pharma Plc Immunicum AB Jiangsu Hengrui Medicine Co., Ltd. Kolltan Pharmaceuticals, Inc. Natco Pharma Limited Nerviano Medical Sciences S.r.l. Novartis AG Omeros Corporation